EV/EBITDA:
44.01-0.80(-1.79%)Summary
- As of today, STOK EV/EBITDA is 44.01, with a fall of -0.80 (-1.79%) during the most recent trading session on November 19, 2025.
- Over the past year, STOK EV/EBITDA has increased by +47.39 (+1402.07%).
- STOK EV/EBITDA is now -19.53% below its all-time high of 54.69.
Performance
STOK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
STOK EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.8% | -1.8% | -1.5% |
| 1M1 Month | -13.8% | -13.8% | -15.1% |
| 3M3 Months | +155.4% | +79.9% | +54.0% |
| 6M6 Months | +923.5% | +653.8% | +189.7% |
| YTDYTD | +1211.4% | +260.4% | +158.2% |
| 1Y1 Year | +1402.1% | +263.1% | +145.3% |
| 5Y5 Years | +280.6% | +17.7% | -30.2% |
STOK EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 53.08 | -17.1% | 32.91 | +33.7% |
| 3M | 3-Month | 54.69 | -19.5% | 17.23 | +155.4% |
| 6M | 6-Month | 54.69 | -19.5% | 3.47 | +1168.3% |
| 1Y | 1-Year | 54.69 | -19.5% | -4.91 | +996.3% |
| 3Y | 3-Year | 54.69 | -19.5% | -6.51 | +776.0% |
| 5Y | 5-Year | 54.69 | -19.5% | -44.11 | +199.8% |
| All-Time | All-Time | 54.69 | -19.5% | -131.22 | +133.5% |
STOK EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 44.01(+1211.4%) |
| 2024 | -3.96(-820.9%) |
| 2023 | -0.43(+68.8%) |
| Date | Value |
|---|---|
| 2022 | -1.38(+82.8%) |
| 2021 | -8.00(+79.2%) |
| 2020 | -38.50(-91.5%) |
| 2019 | -20.10 |
FAQ
- What is Stoke Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Stoke Therapeutics, Inc.?
- What is STOK EV/EBITDA year-to-date change?
- What is Stoke Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Stoke Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of STOK is 44.01
What is the all-time high EV/EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high EV/EBITDA is 54.69
What is STOK EV/EBITDA year-to-date change?
Stoke Therapeutics, Inc. EV/EBITDA has changed by +47.97 (+1211.36%) since the beginning of the year
What is Stoke Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, STOK EV/EBITDA has changed by +47.39 (+1402.07%)